• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·IP.BK
Share

Inter Pharma Public Company Limited Stocks

THB 5.4Last Updated 27.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

THB 96.95M

THB 5.4
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in the manufacturing, importing, and distribution of a wide array of health and dietary supplements designed for both human and animal use. The company's operations are divided into two primary segments: Human Healthcare and Animal Healthcare. Its Human Healthcare division provides a diverse range of items including medical supplies, nutritional therapy products, cosmetics, supplemental foodstuffs, probiotic and prebiotic offerings, health-focused and general food products, medical devices, and pharmaceutical medicines. This segment also extends to wellness and anti-aging solutions, aesthetic treatments like anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals, as well as diagnostic tools. For the Animal Healthcare sector, Inter Pharma caters to pets and livestock with veterinary provisions, nutritional support, vaccines, supplementary feeds, probiotic and prebiotic formulations, specialized animal health foods, premium and standard animal feeds, nutraceuticals, medicated shampoos, animal cosmeceuticals, and general pet and livestock food products. The company was founded in 2006 and is headquartered in Bangkok.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

29.07.2026 20:35

Noble is first on Wall St. to cover Beasley Broadcast Group, seeing almost 50% upside

29.07.2026 19:56

"The Focus Is Back on Iran": U.S. Stocks See a Sell-Off Ahead of the Fed's Decision

29.07.2026 19:38

"I've been through hell": July could be the worst month in history for Korean stocks

29.07.2026 19:23

Nuclear Resilience: Which Companies Made the List of the World's Most Valuable Mining Companies?

29.07.2026 18:09

Oil prices soared 7% after Trump's remarks about a U.S. retaliatory strike against Iran

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026